Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
https://www.cantonstrategic.comSEC filings for CNTN on EDGAR
No Form 4 activity for CNTN in the last 90 days.
16 Form 4 filings on record, the earliest from Oct 8, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 10,000 | $3.45 | $35K | ||
| Open-market sale | Common Stock | 10,000 | $3.45 | $35K | ||
| Open-market sale | Common Stock | 15,000 | $3.40 | $51K | ||
| Open-market sale | Common Stock | 15,000 | $3.41 | $51K | ||
| Open-market sale | Common Stock | 15,000 | $3.41 | $51K | ||
| Open-market sale | Common Stock | 10,000 | $3.40 | $34K | ||
| Open-market sale | Common Stock | 12,851 | $3.44 | $44K | ||
| Open-market sale | Common Stock | 12,500 | $3.47 | $43K | ||
| Grant or award | Stock Option | 90,000 | $0.00 | - | ||
| Grant or award | Stock Option | 32,500 | $0.00 | - | ||
| Gravitas Capital LP - 10% Owner | Grant or award | Stock Option | 90,000 | $0.00 | - | |
| Sireesh Appajosyula - Officer | Grant or award | Stock Option | 20,000 | $0.00 | - | |
| Thomas Clay Kahler - Director | Grant or award | Stock Option | 17,500 | $0.00 | - | |
| Grant or award | Stock Option | 5,000 | $0.00 | - | ||
| Sanam Parikh - Officer | Grant or award | Stock Option | 5,000 | $0.00 | - | |
| Nancy Davis Rickel - Director | Grant or award | Stock Option | 5,000 | $0.00 | - | |
| Sireesh Appajosyula - Officer | Grant or award | Stock Option | 90,000 | $0.00 | - | |
| Sanam Parikh - Director | Grant or award | Stock Option | 50,000 | $0.00 | - | |
| Kelly Anderson - Director | Grant or award | Common Stock | 6,300 | $0.00 | - | |
| Randy Milby - Officer | Open-market purchase | Common Stock | 4,600 | $2.12 | $10K | |
| Sireesh Appajosyula - Officer | Open-market purchase | Common Stock | 5,000 | $2.02 | $10K | |
| Randy Milby - Officer | Open-market purchase | Common Stock | 1,500 | $2.09 | $3K | |
| Randy Milby - Officer | Open-market purchase | Common Stock | 646 | $2.09 | $1K | |
| Randy Milby - Officer | Open-market purchase | Common Stock | 354 | $2.10 | $743 | |
| Sireesh Appajosyula - Officer | Open-market purchase | Common Stock | 5,000 | $1.93 | $10K |
Tharimmune, Inc. (CNTN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-27. The full record for CNTN runs to 16 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CNTN were filed in the last 90 days. 6 purchases are on record for this company.
No insider sales of CNTN were filed in the last 90 days. 8 sales are on record for this company.
This page tracks CNTN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CNTN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.